Results 61 to 70 of about 16,622 (148)

Engineering of tetanus toxoid-loaded polymeric microneedle patches. [PDF]

Drug Deliv Transl Res, 2023
Arshad MS, Gulfam S, Zafar S, Jalil NA, Ahmad N, Qutachi O, Chang MW, Singh N, Ahmad Z.   +8 more
europepmc   +1 more source

Purification of tetanus toxoid [PDF]

Biochemical Journal, 1942
P. J. Moloney, Joan N. Hennessy
openaire   +3 more sources

A minority of proliferating human CD4+ T cells in antigen-driven proliferation assays are antigen specific

Frontiers in Immunology
Antigen-driven T-cell proliferation is often measured using fluorescent dye dilution assays, such as the CFSE-based proliferation assay. Dye dilution assays have been powerful tools to detect human CD4+ T-cell responses, particularly against autoantigens.
Pushpak Bhattacharjee, Miha Pakusch, Matthew Lacorcia, Chris Y. Chiu, Xin Liu, Xin Liu, Eleonora Tresoldi, Abby Foster, Laura King, Fergus J. Cameron, Fergus J. Cameron, Fergus J. Cameron, Stuart I. Mannering, Stuart I. Mannering, Stuart I. Mannering, Stuart I. Mannering, Stuart I. Mannering   +16 more
doaj   +1 more source

Annual two-dose tetanus toxoid vaccination induces protective humoral immunity to all age groups of rhesus macaques. [PDF]

Exp Anim, 2023
Murata M, Kovba A, Kaneko A, Morimoto M, Ishigami A, Natsume T, Washizaki A, Miyabe-Nishiwaki T, Suzuki J, Akari H.   +9 more
europepmc   +1 more source

Immune responses against group B Streptococcus monovalent and pentavalent capsular polysaccharide tetanus toxoid conjugate vaccines in Balb/c mice. [PDF]

iScience, 2023
Dhar N, Mohamed E, Kirstein F, Williams M, Dorasamy S, van Zyl P, Robertson MJ, Anderson T, Harden LM, Jardine K, Veeraraghavan B, Wilson S, Tippoo P, Madhi SA, Kwatra G.   +14 more
europepmc   +1 more source

Living standard and access to tetanus toxoid immunization among women in Bangladesh. [PDF]

BMC Public Health, 2022
Islam UN, Sen KK, Bari W.
europepmc   +1 more source

Tetanus and Diphtheria Toxoid-Containing Vaccine in Multiple Sclerosis Patients: A Real-World Prospective, Open-Label, Multi-Centre Study

Vaccines
Objective: To assess changes in disease activity in Multiple Sclerosis (MS) patients on various disease-modifying-drugs, as well as immunogenicity, safety and clinical tolerability following combined tetanus- and diphtheria-vaccination.
Alexander Winkelmann, Emil C. Reisinger, Katharina Boden, Christoph Metze, Uwe K. Zettl, Micha Loebermann   +5 more
doaj   +1 more source

Quadrivalent meningococcal tetanus toxoid-conjugate booster vaccination in adolescents and adults: phase III randomized study. [PDF]

Pediatr Res, 2023
Zambrano B, Peterson J, Deseda C, Julien K, Spiegel CA, Seyler C, Simon M, Hoki R, Anderson M, Brabec B, Áñez G, Shi J, Pan J, Hagenbach A, Von Barbier D, Varghese K, Jordanov E, Dhingra MS.   +17 more
europepmc   +1 more source

Effect of Plasmodium Infection during Pregnancy on Passive Neonatal Immunity against Tetanus Toxoid and Rotavirus. [PDF]

Am J Trop Med Hyg, 2022
Álvarez-Larrotta C, Agudelo OM, Gavina K, Yanow SK, Carmona-Fonseca J, Arango E.   +5 more
europepmc   +1 more source

A randomized, observer-blind, controlled phase III clinical trial assessing safety and immunological non-inferiority of Vi-diphtheria toxoid versus Vi-tetanus toxoid typhoid conjugate vaccine in healthy volunteers in eastern Nepal. [PDF]

Hum Vaccin Immunother, 2023
Chaudhary S, Shah GS, Bhatta NK, Poudel P, Rai B, Uranw S, Tripathi PM, Khanal B, Ghimire A, Rai N, Gupta BP, Vemula S, Wartel TA, Sahastrabuddhe S, Saluja T.   +14 more
europepmc   +1 more source